Clinical Trial Update: Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP [NA]

View source ↗

Summary

Clinical trial update shows the Emesis Control Study in Non-Hodgkin lymphoma patients receiving R-CHOP has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Australasian Leukaemia and Lymphoma Group | Conditions: Lymphoma, Non-Hodgkin | NA | Status: WITHDRAWN